The COVID-19 pandemic is possessing a profound impact on medical center finances, exemplified by data showing that running EBITDA margins fell a dramatic 174% in April, and remained down 9% 12 months-over-12 months in May possibly. So much, while, mergers and acquisition exercise hasn’t taken as major a blow. Transaction volumes are down from the norm, but only marginally, suggesting the general public overall health disaster may perhaps be strengthening the rationale for future partnerships.
In accordance to second-quarter data from Kaufman Hall, there were being fourteen transactions introduced in the quarter. That’s a dip from the 29 transactions recorded
